山河药辅 (300452)
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 23444.99
- Circulating A-Shares(W): 18680.25
- Earnings Per Share(RMB): 0.5700
- Net Assets Per Share(RMB): 3.9788
- Operating Revenue(W RMB): 69650.27
- Total Profit(W RMB): 15036.46
- Net Profit Attributable to Parent(W RMB): 13256.39
- Net Profit Growth Rate(%): 8.28
- Weighted Return on Equity(%): 13.6900
- Operating Cash Flow Per Share(RMB): 0.4400
- Undistributed Profit Per Share(RMB): 2.3507
- Capital Reserve Per Share(RMB): 0.2795
2. Main Business
The main business covers:
- Research, development, production, and sales of pharmaceutical excipients.
3. Company Basic Information
- Company Name: Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
- Listing Date: 2015-05-15
- Industry: Pharmaceutical Manufacturing
- Address: No.2 Hebin Road, Economic and Technological Development Zone, Huainan City, Anhui Province, China.
- Website: www.shanhe01.com
- Company Profile:The Company was established by all shareholders of Anhui Sunhere Pharmaceutical Excipients Co., Ltd. as promoters. Based on the audited net assets of Sunhere Co., Ltd. as of June 30, 2009, amounting to RMB 27.6109 million, it was converted into 26.10 million shares at a ratio of 1:0.945, and was legally transformed into a joint stock limited company. The Company was registered with the Huainan Administration for Industry and Commerce on August 6, 2009, with registration number 340404000000525, and the legal representative was Yin Zhenglong.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | General Legal Person | 2164.53 | 11.59 |
| 2 | Xinhua Pension Tonghai Wenjin No.2 Equity Pension Product - Bank of China Limited | General Legal Person | 168.99 | 0.90 |
5. Concept Sectors
- Convertible Bonds
- Generic Drugs
- Medical Aesthetics Concept
- Synthetic Biology
- High-Performance Stocks
- Specialized, Refined, Distinctive, and Innovative SMEs
- Small-Cap Non-Marginable Stocks
- Control Change
- Micro and Small-Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
